{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:11:17Z","timestamp":1789373477672,"version":"build-2803163510"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,10]]},"DOI":"10.18632\/oncotarget.8539","type":"journal-article","created":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T16:27:46Z","timestamp":1459528066000},"page":"27838-27847","source":"Crossref","is-referenced-by-count":34,"title":["Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Xunjun","family":"Yang","sequence":"first","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"Department of Laboratory Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchan","family":"Guo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang, China"},{"name":"ICF International, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Ma","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongya","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Winkler","sequence":"additional","affiliation":[{"name":"Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"An","sequence":"additional","affiliation":[{"name":"Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Lyu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"Rudolph","year":"2007","journal-title":"Gastroenterology"},{"key":"2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"He","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"crossref","first-page":"e1001624","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Tiro","year":"2014","journal-title":"PLoS Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Bruix","year":"2012","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.18632\/oncotarget.2913","article-title":"Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Feitelson","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsmb.1777","article-title":"Structural basis for telomerase catalytic subunit TERT binding to RNA template and telomeric DNA","volume":"17","author":"Skordalakes","year":"2010","journal-title":"Nature structural & molecular biology"},{"key":"8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2014.05.028","article-title":"TERT promoter mutations: Gatekeeper and driver of hepatocellular carcinoma","volume":"61","author":"Llovet","year":"2014","journal-title":"J Hepatol"},{"key":"9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Shay","year":"1994","journal-title":"Science"},{"key":"10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s11427-014-4666-6","article-title":"Telomerase as a \u201cstemness\u201d enzyme","volume":"57","author":"Xu","year":"2014","journal-title":"Science China Life Sciences"},{"key":"11","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Mandahl","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Garraway","year":"2013","journal-title":"Science"},{"key":"13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Kumar","year":"2013","journal-title":"Science"},{"key":"14","doi-asserted-by":"publisher","first-page":"19542","DOI":"10.18632\/oncotarget.4295","article-title":"The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer","volume":"6","author":"Fan","year":"2015","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.18632\/oncotarget.1829","article-title":"TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Bishop","year":"2014","journal-title":"J Clin Oncol"},{"key":"17","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/cncr.28800","article-title":"TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA","volume":"120","author":"Xu","year":"2014","journal-title":"Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","article-title":"TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer","volume":"99","author":"Xing","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2013.11.005","article-title":"TERT promoter mutations in cancer development","volume":"24","author":"Kumar","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"20","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Zucman-Rossi","year":"2013","journal-title":"Nat Commun"},{"key":"21","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"Zucman-Rossi","year":"2014","journal-title":"Hepatology"},{"key":"22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijsu.2014.05.066","article-title":"TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection","volume":"12","author":"Yuan","year":"2014","journal-title":"Int J Surg"},{"key":"23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00428-014-1658-7","article-title":"Frequency of TERT promoter mutations in primary tumors of the liver","volume":"465","author":"Grob","year":"2014","journal-title":"Virchows Archiv"},{"key":"24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3748\/wjg.v21.i1.311","article-title":"Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations","volume":"21","author":"Ozturk","year":"2015","journal-title":"World J Gastroenterol"},{"key":"25","article-title":"Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features","author":"Itsui","year":"2015","journal-title":"J Gastroenterol"},{"key":"26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2009.133124","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers","volume":"56","author":"Taketa","year":"2010","journal-title":"Clin Chem"},{"key":"27","first-page":"10","article-title":"Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition)","volume":"1","author":"Primary Liver Cancer","year":"2012","journal-title":"Chin Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.20279","article-title":"High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations","volume":"112","author":"Hsu","year":"2004","journal-title":"Int J Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.18632\/oncotarget.6913","article-title":"Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00428-014-1608-4","article-title":"Telomerase promoter mutations in cancer: an emerging molecular biomarker?","volume":"465","author":"Soares","year":"2014","journal-title":"Virchows Arch"},{"key":"31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ng.2295","article-title":"Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma","volume":"44","author":"Chan","year":"2012","journal-title":"Nat Genet"},{"key":"32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4149\/neo_2010_03_222","article-title":"Nuclear translocation of telomerase reverse transcriptase: a critical process in chemical induced hepatocellular carcinogenesis","volume":"57","author":"Kong","year":"2010","journal-title":"Neoplasma"},{"key":"33","first-page":"319","article-title":"Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?","volume":"29","author":"Papaioannou","year":"2009","journal-title":"Anticancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2014.93","article-title":"Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation","volume":"28","author":"Kuo","year":"2015","journal-title":"Mod Pathol"},{"key":"35","first-page":"4","article-title":"Frequency of TERT promoter mutations in human cancers","author":"Lima","year":"2013","journal-title":"Nature communications"},{"key":"36","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/onc.2013.446","article-title":"The age-and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas","volume":"33","author":"Xu","year":"2014","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/nou158","article-title":"TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas","volume":"17","author":"Kumar","year":"2015","journal-title":"Neuro Oncol"},{"key":"38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ydbio.2012.11.020","article-title":"Deciphering gene expression program of MAP3K1 in mouse eyelid morphogenesis","volume":"374","author":"Xia","year":"2013","journal-title":"Dev Biol"},{"key":"39","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F","article-title":"World Health Organization classification of tumors","volume":"88","author":"Sobin","year":"2000","journal-title":"Cancer"},{"key":"40","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9","article-title":"TNM classification of malignant tumors, fifth edition (1997)","volume":"80","author":"Fleming","year":"1997","journal-title":"Cancer"},{"key":"41","first-page":"e2763","article-title":"DNA extraction from paraffin embedded material for genetic and epigenetic analyses","author":"Lam","year":"2011","journal-title":"J Vis Exp"},{"key":"42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2005.04.035","article-title":"Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study","volume":"98","author":"Brustmann","year":"2005","journal-title":"Gynecologic oncology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:56:55Z","timestamp":1589212615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":42,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2016,5,10]]}},"alternative-id":["8539","27056898"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8539","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}